We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...
We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...
Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...
Another biotech startup revealed plans Friday evening for an initial public offering, making it the sixth startup to list new ...
An office and lab property in Thousand Oaks has sold in an all-cash transaction. Los Angeles-based Alta West Partners and an ...
A rare-disease federal incentive program critical to biotech R&D is in jeopardy, writes Leslie Williams, president and CEO of ...
US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold ...
A rather odd week in venture, as the biggest rounds were raised by greentech, business travel and charity startups. Of course ...
An early-stage biotech investor called YK Bioventures plans to raise $100 million, according to an SEC filing on Wednesday.
Unlike previous DNA computers, the data can be erased and replaced like memory on classical computers to solve multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback